Financial

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected...

Red Sky Health Unveils Its Powerful AI Platform Daniel – Enables Healthcare Providers to Secure Lost Revenue by Recapturing Denied Claims

Leveraging machine learning, new solution analyzes historical claims data to identify errors, streamline resubmissions and recover lost income NEW YORK,...

Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company’s Next Chapter of Commercial Growth and Product Innovation

Accomplished industry leader brings specialized experience to advance Freenome's screening blood tests for colorectal cancer, lung cancer and additional indications...

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted...

Exactech Unveils Next Generation of Predict+®, the First Machine Learning Tool for Predictive Outcomes in Shoulder Replacement Surgery

GAINESVILLE, Fla., April 7, 2025 /PRNewswire/ -- Exactech, a global medical technology leader, announced the launch of the next generation...

Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization

Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming...

TALON selects Litchfield Underwriters to provide Comprehensive Stop-Loss Coverage for Transformative Equitable Healthcare Pricing Network

PORTSMOUTH, N.H., April 4, 2025 /PRNewswire/ -- Litchfield Underwriters, industry leaders in providing superior self-funded reinsurance solutions to commercial clients,...

NETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION

TORONTO, April 3, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial...

error: Content is protected !!